Announcements Trials
Browse Landscape

Phase

Phase 3 35Phase 2 25Phase 1/2 12Phase 1 9Phase 2/3 6Phase NA 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Standard of Care 24Interviews as Topic 21Specimen Handling 19Educational Status 19Early Intervention, Educational 19Practice Guidelines as Topic 18Methods 17Exercise 17Surveys and Questionnaires 10Radiosurgery 10Magnetic Resonance Spectroscopy 10Palliative Care 9Patient Navigation 8Diet Therapy 8Blood Specimen Collection 8Counseling 7Surgical Procedures, Operative 5Radiotherapy 5Magnetic Resonance Imaging 5Genetic Testing 5Biopsy 5fludarabine 4Radiation Dose Hypofractionation 4Nutrition Assessment 4Mastectomy, Segmental 4Human Papillomavirus DNA Tests 4Health Promotion 4Dietary Supplements 4Diet, Ketogenic 4Colposcopy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Pemetrexed × 30 days × Clear all
NCT02194738 2026-05-13

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

National Cancer Institute (NCI)

Phase NA Active not recruiting
8,300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡